SEC Form 5 · accession 0001209191-16-090562
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Dec 31, 2015
Accepted (ET)
Jan 8, 2016 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 23, 2015 | G | 1,000 | $0.00 | D | 32,748 | D |
Table II — derivative securities
No Table II lines on this filing.